Post COVID fatigue: AETL’ supplements pass trials
The Hindu
Study was conducted on 200 patients across three centres
Advanced Enzyme Technologies Ltd (AETL) has said its systemic enzyme and probiotic supplements—ImmunoSEB and ProbioSEB CSC3 have passed the randomised controlled clinical trials in terms of efficacy to resolve post COVID-19 fatigue symptoms. “With an aim to evaluate the efficacy and safety of the health supplements, ImmunoSEB [systemic enzyme complex] and ProbioSEB CSC3 [probiotic complex] in patients suffering from COVID-19 induced fatigue, a randomised, multi-centric, double blind and placebo-controlled trial was conducted in 200 patients suffering from post COVID-19 fatigue symptoms,” said Dr. Abhijit K. Rathi, Principal Scientist, AETL. “The randomized clinical trial was conducted on 200 patients who did not have an active SARS-CoV-2 infection, as determined by a negative COVID-19 test, with a complaint of post COVID-19 fatigue,” he stated.More Related News

What began as a simple way to stay active soon grew into something larger. The couple converted the garden of their Ashok Nagar residence into a pickleball court, now known as Pickleball Point, envisioning it as a lively space where people from all age groups could gather, play and connect. “It started at home, as something for my husband and me to stay engaged,” she says. “As senior citizens, we wanted to enjoy the energy of people coming in and playing,” she further adds.












